BMC Pulmonary Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2023-06-02 ms5000001956621569

质量检查快一个月了，只有我是这样吗，哭死

79 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2023-11-11 ms8000000465818220 来自安徽省

Editor Invited 已经一个多月了啊，怎么搞

20 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2023-11-23 hstb 来自北京

审稿速度:6.0
偏重的研究方向：呼吸科;队列研究;临床
经验分享：速度偏慢

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2023-11-03 ms2000001878750293 来自宁夏

审稿速度:4.0 | 投稿命中率:75.0
偏重的研究方向：肺肿瘤
经验分享：省了半年前面一直找不到审稿人

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2023-09-26 147ab6f6m58(暂无昵称) 来自浙江省

ss

42 0

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2023-09-15 ms3000000776207476 来自黑龙江省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：呼吸科
经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2023-04-04 146d3b97m12(暂无昵称) 来自陕西省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肺癌
经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。

91 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2023-05-26 ms5000001401005050 来自山东省

审稿速度:1.0
偏重的研究方向：队列研究;肺结核
经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？

73 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2023-07-18 ms4000000550523581 来自宁夏

偏重的研究方向：呼吸介入
经验分享：投稿中

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0 偏重的研究方向：呼吸科;队列研究;临床 经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0 偏重的研究方向：肺肿瘤 经验分享：省了半年前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：呼吸科 经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0 偏重的研究方向：队列研究;肺结核 经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2148640, encodeId=2487214864055, content=偏重的研究方向：呼吸介入 经验分享：投稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa038751640, createdName=ms4000000550523581, createdTime=Tue Jul 18 18:13:17 CST 2023, time=2023-07-18, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=)]

2021-09-26 huanhuan871002_19261827

第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗

146 11

展开11条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务